Entry

D06753            Crude     Drug

Name

Mulberry bark (JP18);
Mulberry bark (TN)

Component

Morusin [CPD:C10106], Kuwanone G [CPD:C10099], Kuwanone H [CPD:C10100], Mulberrofuran A [CPD:C08846], Mulberrofuran C [CPD:C08928], Mulberrofuran G [CPD:C08738], Cyclomorusin [CPD:C17867], Sanggenon A [CPD:C17869], Sanggenon B [CPD:C17870], Sanggenon C [CPD:C09834], Sanggenon D [CPD:C09835], Sanggenon E [CPD:C17871], alpha-Amyrin [CPD:C08615], beta-Amyrin [CPD:C08616], Moranolin [CPD:C16843], Morusinol [CPD:C17868], Betulinic acid [CPD:C08619], Sitosterol [CPD:C01753], Sitogluside [DR:D05848], Palmitic acid [CPD:C00249], Stearic acid [CPD:C01530], Adenine [CPD:C00147], Betaine [CPD:C00719], Umbelliferone [CPD:C09315], Scopoletin [CPD:C01752], Triterpene, Kuwanone A-H

Source

Morus alba [TAX:3498]

Remark

Therapeutic category:

5100

Product:

D06753<JP>

Efficacy

Hypoglycemic

Comment

Moraceae (mulberry family) Mulberry bark
Major component: Morusin [CPD:C10106]

Brite

Therapeutic category of drugs in Japan [BR:br08301]
5  Crude drugs and Chinese medicine formulations
  51  Crude drugs
   510  Crude drugs
    5100  Crude drugs
     D06753  Mulberry bark (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for circulatory system and blood
  25 Other drugs for circulatory system and blood
   D06753  Mulberry bark (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
  Crude drugs
   Mulberry bark
    D06753  Mulberry bark (JP18)
Traditional Chinese Medicine in Japan [BR:br08304]
Crude drugs
  Drugs for dampness
   Cough suppressants and expectorants
    D06753  Mulberry bark; Mulberry bark
Crude drugs [BR:br08305]
Dicot plants: rosids
  Moraceae (mulberry family)
   D06753  Mulberry bark
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
  D06753  Mulberry bark

Other DBs

PubChem:

47208404